Breast cancer management during COVID-19 pandemic has changed and in case of COVID-19 patients with simultaneous neoplasia, it has been strongly recommended to treat Sars-CoV-2 infection firstly.
Pellicciaro, M., Granai, A.v., Marchese, G., Materazzo, M., Cotesta, M., Santori, F., et al. (2020). Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 76, 377-380 [10.1016/j.ijscr.2020.10.020].
Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings
Granai, Alessandra VittoriaMembro del Collaboration Group
;Giacobbi, EricaMembro del Collaboration Group
;Servadei, FrancescaMembro del Collaboration Group
;Grelli, SandroMembro del Collaboration Group
;Perretta, TommasoMembro del Collaboration Group
;Pistolese, Chiara Adriana;Vanni, Gianluca
2020-01-01
Abstract
Breast cancer management during COVID-19 pandemic has changed and in case of COVID-19 patients with simultaneous neoplasia, it has been strongly recommended to treat Sars-CoV-2 infection firstly.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
